dehydrated alcohol injection

Drug Overview

Dehydrated alcohol injection is a highly specialized medication, primarily utilized within the intersection of cardiology and vascular medicine, and closely monitored by hematology and interventional specialists. Classified as a Sclerosing Agent, it is a potent, non-biologic chemical designed to permanently alter specific tissues.

For patients suffering from Hypertrophic Obstructive Cardiomyopathy (HOCM)—a condition where the heart muscle becomes abnormally thick and blocks blood flow—this medication offers a life-changing, minimally invasive alternative to open-heart surgery. By acting as a Targeted Therapy, it strategically reduces the overgrown muscle, allowing blood to flow freely from the heart to the rest of the body.

• Generic Name: dehydrated alcohol injection (ethanol)
• US Brand Names: Ablysinol
• Drug Category: Cardiology / Vascular Hematology
• Drug Class: Sclerosing Agent / Tissue Ablation Agent
• Route of Administration: Intracoronary Injection (delivered directly into a specific artery of the heart via a catheter)
• FDA Approval Status: FDA-approved to induce a localized controlled myocardial infarction (heart attack) to treat symptomatic hypertrophic obstructive cardiomyopathy in adults.

What Is It and How Does It Work? (Mechanism of Action)

To understand how dehydrated alcohol injection works, it is important to understand the physical mechanics of Hypertrophic Obstructive Cardiomyopathy (HOCM). In HOCM, the septum (the muscular wall separating the left and right sides of the heart) becomes massively enlarged. This thick muscle acts like a boulder blocking a stream, preventing oxygen-rich blood from easily leaving the heart’s main pumping chamber (the left ventricle).

Dehydrated alcohol is nearly 100% pure ethanol. When used in a procedure called “Alcohol Septal Ablation,” it acts as an immediate, irreversible cellular toxin.

The procedure works by threading a tiny catheter through the vascular system into a specific, small artery (a septal perforator branch) that supplies blood exclusively to the overgrown part of the heart muscle. Once the catheter is in the exact right spot, a very small amount of the dehydrated alcohol is injected directly into that specific artery.

At the cellular and vascular level, the absolute alcohol causes immediate and profound damage to the blood vessels and the muscle cells it touches. It denatures (unwinds and destroys) the proteins inside the cells, causing instantaneous cell death (necrosis). Furthermore, it causes severe endothelial injury—stripping the lining of the small blood vessels—which immediately triggers localized thrombosis (clotting) within that specific artery, permanently shutting off its blood supply.

By intentionally destroying this small, targeted section of the overgrown muscle (essentially creating a controlled, localized heart attack), the tissue eventually scars and shrinks. As the “boulder” shrinks, the blockage is relieved, and normal blood flow out of the heart is restored.

FDA-Approved Clinical Indications

Primary Indication

The primary, FDA-approved use for dehydrated alcohol injection in this highly specialized setting is the treatment of highly symptomatic adult patients with Hypertrophic Obstructive Cardiomyopathy (HOCM). It is indicated for patients who continue to suffer from severe symptoms (such as fainting, severe shortness of breath, and chest pain) despite trying maximum medical therapies (like beta-blockers or calcium channel blockers), and who are not ideal candidates for open-heart surgery to cut out the muscle.

Other Approved & Off-Label Uses

Because absolute alcohol is a potent Sclerosing Agent (a chemical that intentionally destroys tissue and veins), it has several other targeted uses in vascular medicine and hematology:

• Vascular Malformations (Off-Label): Injected by interventional radiologists to intentionally clot and destroy dangerous tangles of abnormal blood vessels (arteriovenous malformations or venous angiomas).
• Nerve Blocks (Off-Label): Used for permanent destruction of nerve tissue to manage severe, intractable pain (neurolysis).

Dosage and Administration Protocols

The administration of dehydrated alcohol for septal ablation is an incredibly delicate, high-risk procedure performed only by specialized interventional cardiologists in a cardiac catheterization lab. The dose is exceptionally small and precise.

Important Adjustments:

• Echocardiographic Guidance: The absolute volume injected is determined in real-time. The physician uses myocardial contrast echocardiography (specialized ultrasound dye) to confirm the catheter is only supplying the overgrown muscle. If the dye shows the alcohol might leak into other critical heart tissues, the procedure is aborted.
• Maximum Volume: The total dose rarely exceeds 2 mL, as larger volumes significantly increase the risk of massive, fatal tissue destruction and complete heart block.
• Organ Function: Because the dose is so small and acts immediately and locally, standard dose adjustments for systemic renal or hepatic insufficiency are not typically required, though overall patient stability is assessed prior to the procedure.

Clinical Efficacy and Research Results

Clinical data from 2020 through 2025 continues to support Alcohol Septal Ablation as a highly efficacious alternative to surgical myectomy for appropriate patients.

In long-term clinical registries, approximately 80% to 90% of patients who undergo the procedure experience a significant, sustained reduction in their outflow tract gradient (the pressure measurement of the blood flow blockage). This physical improvement translates directly to symptom relief: patients report massive improvements in their ability to exercise without shortness of breath, a near-total resolution of fainting spells, and an overall survival rate that is comparable to patients who undergo open-heart surgery.

Safety Profile and Side Effects

Black Box Warning

There is no FDA Black Box Warning explicitly for dehydrated alcohol injection; however, the prescribing information heavily emphasizes that it must only be used by physicians highly trained in its specific administration, as accidental injection into the wrong area is fatal.

Common side effects (>10%)

Because the goal of the procedure is to cause a controlled heart attack, the immediate side effects mirror that event:

• Chest pain (angina) during and immediately following the injection
• Mild to moderate shortness of breath
• Transient changes in blood pressure

Serious adverse events

• Complete Heart Block: The electrical system of the heart runs very close to the targeted muscle. The alcohol can destroy this electrical pathway, requiring the permanent implantation of a pacemaker in roughly 10% to 20% of patients.
• Ventricular Fibrillation/Cardiac Arrest: The dying muscle cells can trigger chaotic, fatal heart rhythms during or shortly after the procedure.
• Massive Myocardial Infarction: If the alcohol leaks backward into the main coronary arteries, it can destroy large, vital sections of the heart muscle, leading to severe heart failure or death.

Management Strategies

Due to the high risk of fatal arrhythmias, patients are kept in a cardiac intensive care unit (ICU) for at least 48 to 72 hours following the injection. A temporary pacemaker is almost always inserted through a vein in the groin before the alcohol is injected, ensuring that if the heart’s electrical system fails, the temporary pacemaker can immediately take over until a permanent one is placed.

Research Areas

Current research is focused on minimizing the most common complication: the need for a permanent pacemaker. Investigators are studying whether even smaller, more precisely targeted “micro-doses” of alcohol can achieve the same muscle shrinkage while avoiding the electrical pathways entirely. Additionally, trials are comparing alcohol ablation against newer, non-invasive therapies (like cardiac myosin inhibitors) to determine the absolute safest long-term strategy for managing HOCM.

Disclaimer: These studies regarding ultra-low-dose alcohol ablation, conduction-system avoidance, and direct comparisons with cardiac myosin inhibitors in HOCM are still evolving and are not yet applicable as universally standardized clinical protocols. While dose optimization and alternative therapies are under active investigation, the idea that “micro-doses” can reliably avoid pacemaker risk or that any one approach represents the absolute safest long-term strategy remains exploratory and not definitively proven.

Patient Management and Practical Recommendations

Pre-treatment Tests

• Comprehensive Echocardiogram: To precisely measure the thickness of the heart muscle and the severity of the blockage.
• Cardiac MRI: Often used to map the exact anatomy of the heart and its blood supply before the procedure.
• Coagulation Studies: Baseline PT/INR and aPTT, as blood thinners are often used during the catheter procedure to prevent unwanted clotting on the equipment.

Precautions during treatment

• Continuous Monitoring: Real-time, continuous ECG and blood pressure monitoring is mandatory during the procedure and for several days afterward.
• Vigilance for Stroke: Because catheters are threaded through the arterial system, there is always a risk of dislodging plaque and causing a stroke; neuro-checks must be performed post-operatively.

“Do’s and Don’ts” List

• DO ensure you are treated at a “Center of Excellence”—a hospital that performs a high volume of these specific procedures annually.
• DO arrange for someone to stay with you for the first week after you return home from the hospital.
• DO report any new dizziness, racing heartbeats, or fainting spells to your cardiologist immediately, as these can be signs of delayed electrical problems.
• DON’T perform any heavy lifting or strenuous exercise for several weeks following the procedure to allow the heart muscle to scar and heal properly.
• DON’T stop taking your prescribed antiplatelet medications (like aspirin or clopidogrel) after the procedure unless explicitly instructed, as they prevent clots from forming on the healing tissues.

Legal Disclaimer

For informational purposes only; this guide does not replace professional medical advice from a qualified healthcare provider. The information within this guide is intended to support the understanding of complex medical treatments and is not a substitute for professional medical diagnosis or treatment. Alcohol Septal Ablation is a highly invasive, high-risk procedure; always seek the direct advice of an expert interventional cardiologist regarding treatment protocols, risks, and post-operative management.